Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis

Journal of Bone and Mineral Research

Volumn 22, Issue 8, 2007, Pages 1173-1180

  Chen, Peiqi ^a   Miller, Paul D ^b   Recker, Robert ^c   Resch, Heinrich ^d   Rana, Asad ^a   Pavo, Imre ^a   Sipos, Adrien A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b University of Colorado Health Sciences Center   (United States)

^c CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

CT; Bone microarchitecture; Histomorphometry; Lumbar spine and femoral neck BMD; Teriparatide

Indexed keywords

PARATHYROID HORMONE[1-34]; PLACEBO;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE STRENGTH; BONE STRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL BONE; FEMALE; FEMUR NECK; HUMAN; HUMAN TISSUE; ILIAC CREST; LUMBAR SPINE; MAJOR CLINICAL STUDY; MICRO-COMPUTED TOMOGRAPHY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; TRABECULAR BONE; AGED; DRUG EFFECT; GENERAL APPARATUS, EQUIPMENT AND SUPPLIES; HIP; LUMBAR VERTEBRA; MIDDLE AGED; OSTEOPOROSIS; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; FEMALE; HIP; HUMANS; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS; POSTMENOPAUSE; TERIPARATIDE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 34548076624     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.070413     Document Type: Article

References (43)

1. Bouxsein ML 2003 Bone quality: Where do we go from here? Osteoporos Int 14(Suppl 5):S118-S127.
2. Chesnut CH III, Rose CJ 2001 Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture. J Bone Miner Res 16:2163-2172.
3. Felsenberg D, Boonen S 2005 The bone quality framework: Determinants of bone strength and their interrelationships, and implications for osteoporosis management. Clin Ther 37:1-11.
4. Ravaud P, Reny JL, Giraudeau B, Porcher R, Dougados M, Roux C 1999 Individual smallest detectable difference in bone mineral density measurements. J Bone Miner Res 14:1449-1456.
5. Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Black DM 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281-289.
6. Li Z, Meredith MP, Hoseyni MS 2001 A method to assess the proportion of treatment effect explained by a surrogate end-point. Stat Med 20:3175-3188.
7. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD 2002 Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17:1-10.
8. Watts NB, Cooper C, Lindsay R, Eastell R, Manhart MD, Barton IP, van Staa TP, Adachi JD 2004 Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: Greater increases in bone mineral density do not relate to greater decreases in fracture risk. J Clin Densitom 7:255-261.
9. Lewiecki EM 2003 Nonresponders to osteoporosis therapy. J Clin Densitom 6:307-314.
10. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
11. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF 2003 Recombinant human parathyroid hormone (1-34 [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932-1941.
12. McClung MR, San Martin J, Miller PD, Civitelli R, Bandeira F, Omizo M, Donley DW, Dalsky GP, Eriksen EF 2005 Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med 165:1762-1768.
13. Chen P, Miller PD, Delmas PD, Misurski DA, Krege JH 2006 Change in lumbar spine bone mineral density and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis. J Bone Miner Res 21:1785-1790.
14. Bradbeer JN, Arlot ME, Meunier PJ, Reeve J 1992 Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: Increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone. Clin Endocrinol (Oxf) 37:282-289.
15. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R 2001 Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: A paired biopsy study. J Bone Miner Res 16:1846-1853.
16. Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH 2000 Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis. Bone 27:311-318.
17. Miki T, Nakatsuka K, Naka H, Masaki H, Imanishi Y, Ito M, Inaba M, Morii H, Nishizawa Y 2004 Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. J Bone Miner Res 22:569-576.
18. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT 1980 Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: A multicentre trial. BMJ 280:1340-1344.
19. Lu Y, Ye K, Mathur AK, Hui S, Fuerst TP, Genant HK 1997 Comparative calibration without a gold standard. Stat Med 16:1889-1905.
20. Eriksen EF 1986 Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocr Rev 7:379-408.
21. Jiang Y, Zhao J, Genant HK 2002 Macro and micro imaging of bone architecture. In: Bilezikian JP, Raisz LG, Rodan GA (eds.) Principles of Bone Biology, 2nd ed. Academic Press, San Diego, CA, USA, pp. 1599-1623.
22. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
23. Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM, Wagman RB 2005 Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res 20:962-970.
24. Delmas PD, Hardy P, Garnero P, Dain M 2000 Monitoring individual response to hormone replacement therapy with bone markers. Bone 26:553-560.
25. Garnero P, Darte C, Delmas PD 1999 A model to monitor the efficacy of alendronate treatment in women with osteoporosis using a biochemical marker of bone turnover. Bone 24:603-609.
26. Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD 2000 Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 11:434-442.
27. Dobnig H, Sipos AA, Jiang Y, Fahrleitner-Pammer A, Ste-Marie LG, Gallagher JC, Pavo I, Wang J, Eriksen EF 2005 Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 90:3970-3977.
28. Delmas PD, Fontanges E, Duboeuf F, Boivin G, Chavassieux P, Meunier PJ 1988 Comparison of bone mass measured by histomorphometry on iliac biopsy and by dual photon absorptiometry of the lumbar spine. Bone 9:209-213.
29. Jiang Y, Zhao J, Liao EY, Dai RC, Wu XP, Genant HK 2005 Application of micro-CT assessment of 3-D bone microstructure in preclinical and clinical studies J Bone Miner Metab 23S:122-131.
30. Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, Marcus R, Martin JS 2007 Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 18:69-76.
31. Fazzalari NL, Parkinson IH 1998 Fractal properties of cancellous bone of the iliac crest in vertebral crush fracture. Bone 23:53-57.
32. Kleerekoper M, Villanueva AR, Stanciu J, Rao DS, Parfitt AM 1985 The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int 37:594-597.
33. Oleksik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P 2000 Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Miner Res 15:1368-1375.
34. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409.
35. Recker RR, Kimmel DB 1991 Changes in trabecular microstructure in osteoporosis occur with normal bone remodeling dynamics. J Bone Miner Res 6:S1;S225.
36. Borah B, Dufresne TE, Chmielewski PA, Johnson TD, Chines A, Manhart MD 2004 Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography. Bone 34:736-746.
37. Marcus R, Wang O, Satterwhite J, Mitlak B 2003 The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in post-menopausal women with osteoporosis. J Bone Miner Res 18:18-23.
38. Balena R, Shih MS, Parfitt AM 1992 Bone resorption and formation on the periosteal envelope of the ilium: A histomorphometric study in healthy women. J Bone Miner Res 7:1475-1482.
39. Parfitt AM 2002 Parathyroid hormone and periosteal bone expansion. J Bone Miner Res 17:1741-1743.
40. Amling M, Grote HJ, Posl M, Hahn M, Delling G 1994 Polyostotic heterogeneity of the spine in osteoporosis. Quantitative analysis and three-dimensional morphology. Bone Miner 27:193-208.
41. Dempster DW, Ferguson-Pell MW, Mellish RW, Cochran GV, Xie F, Fey C, Horbert W, Parisien M, Lindsay R 1993 Relationships between bone structure in the iliac crest and bone structure and strength in the lumbar spine. Osteoporos Int 3:90-96.
42. Thomsen JS, Ebbesen EN, Mosekilde L 2002 Predicting human vertebral bone strength by vertebral static histomorphometry. Bone 30:502-508.
43. Myers ER, Hecker AT, Rooks DS, Hipp JA, Hayes WC 1993 Geometric variables from DXA of the radius predict forearm fracture load in vitro. Calcif Tissue Int 52:199-204.